Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Bell

Oral & Maxillofacial Surgery Portland, OR Medical Doctor

NPI 1992704878 CMS profile 226358

4805 Ne Glisan St Ste 11N, Portland, OR 97213

Open in the dashboard

General payments

$155,899

180 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$4,304,155 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Richard Bell of Portland, OR is reported in the CMS Open Payments database as having received $155,899 across 180 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $4,304,155 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $34,061 30
2024 General $14,939 10
2023 General $9,365 17
2022 General $11,655 13
2021 General $4,209 9
2020 General $14,823 25
2019 General $66,846 76

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Bell
  • Oral & Maxillofacial Surgery median
  • Middle half of Oral & Maxillofacial Surgery
  • National median

In program year 2025, general payments to Richard Bell were reported at $34,061. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.

Show as a table
Year Richard Bell Oral & Maxillofacial Surgery median Middle half National median
2019 $66,846 $178 $56–$584 $163
2020 $14,823 $106 $38–$316 $114
2021 $4,209 $165 $57–$511 $132
2022 $11,655 $173 $63–$494 $149
2023 $9,365 $184 $62–$521 $160
2024 $14,939 $197 $65–$603 $164
2025 $34,061 $184 $61–$541 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $45,692 51 payments
  2. Genzyme Corporation $31,871 24 payments
  3. Stryker Corporation $30,719 37 payments
  4. Regeneron Healthcare Solutions, Inc. $26,449 24 payments
  5. EMD Serono, Inc. $14,595 6 payments
  6. E.R. Squibb & Sons, L.L.C. $4,164 10 payments
  7. Intuitive Surgical, Inc. $1,393 13 payments
  8. DePuy Synthes Sales Inc. $356 3 payments
  9. AxoGen $206 3 payments
  10. AstraZeneca Pharmaceuticals LP $133 1 payment
  11. Other $321 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $84,927 19 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $47,210 16 payments
  3. Travel and Lodging $17,722 65 payments
  4. Food and Beverage $6,040 80 payments
Products named General payments · program years 2019–2025
  1. LIBTAYO Oncology $40,290 34 payments
  2. KEYTRUDA $23,813 37 payments
  3. VSP ORTHOGNATHIC $17,525 19 payments
  4. UNIVERSAL MID-FACE $16,899 7 payments
  5. UNIVERSAL MANDIBLE $16,899 7 payments
  6. LIBTAYO Oncology $16,696 13 payments
  7. VSP RECONSTRUCTION $10,879 11 payments
  8. OPDIVO $3,844 9 payments
  9. Da Vinci Surgical System $1,393 13 payments
  10. MANDIBULAR RECON $1,200 1 payment
  11. Other $3,330 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 27 billing codes

Paid by Medicare

$13,930

Medicare's payments for the services billed

Medicare patients

28

Average age 76

Services billed

66

15 women, 13 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 54%
Cancer 43%
Arthritis 43%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
LIBTAYO
  • Regeneron Healthcare Solutions, Inc. $83
$83 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

180 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Oral & Maxillofacial Surgery in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record